ReviewClinical and translational allergy2017
CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report.
Abstract readReview
In one paragraph
Review in Clinical and translational allergy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Knowledge, Attitudes, and Practices on Allergic Rhinitis Environmental Control and Treatment in China.Journal of asthma and allergy · 2026Article
- Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps.Allergologie select · 2023Review
- Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-airClinical and translational allergy · 2023Article
- Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities.Clinical and translational allergy · 2022Article
- ARIA 2019 Care Pathways for Allergic Rhinitis in the Kuwait Health Care System.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2021Review
- Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing.Allergy, asthma & immunology research · 2020Review
- Keep the cat, change the care pathway: A transformational approach to managing Fel d 1, the major cat allergen.Allergy · 2019Article
- The use of nasal over-the-counter agents in the evaluated Polish population. The underrated role of the pharmacist in patient education on medical treatment in patients with allergic rhinitis.Postepy dermatologii i alergologii · 2019Article
- Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2).Journal of thoracic disease · 2019Review
- Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1).Journal of thoracic disease · 2019Article
- Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.Clinical and translational allergy · 2019Review
- Country activities of Global Alliance against Chronic Respiratory Diseases (GARD): focus presentations at the 11th GARD General Meeting, Brussels.Journal of thoracic disease · 2018Article
- Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study.The World Allergy Organization journal · 2018Article
- Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management.Clinical and translational allergy · 2018Review
- Highlights and recent developments in airway diseases in EAACI journals (2017).Clinical and translational allergy · 2018Review
- MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence.Clinical and translational allergy · 2018Review
- POLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project.Clinical and translational allergy · 2018Review
- The Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing.Translational medicine @ UniSaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
99 authors.
J BousquetContre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
G L OnoratoContre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
C BachertUpper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium.
M BarboliniRegione Emilia Romagna - Agenzia Sanitaria e Sociale, Reference Site of the European Innovation Partnership on Healthy and Active Ageing, Bologna, Italy.
A BedbrookContre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
L BjermerDepartment of Respiratory Medicine and Allergology, University Hospital, Lund, Sweden.
J Correia de SousaLife and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
N H ChavannesDepartment of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
A A CruzProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil.
E De Manuel KeenoyKronikgune, International Centre of Excellence in Chronicity Research Barakaldo, Bizkaia Bilbao, Spain.
P DevillierLaboratoire de Pharmacologie Respiratoire UPRES EA220, Pôle des Maladies Respiratoires, Hôpital Foch, Suresnes Université Versailles Saint-Quentin, Versailles, France.
J FonsecaCenter for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
S HunPublic Health Agency Northern Ireland, Belfast, UK.
T KostkaDepartment of Geriatrics, Medical University of Lodz, Healthy Ageing Research Centre (HARC), Lodz, Poland.
P W HellingsLaboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Louvain, Belgium.
M IllarioDivision for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
J C IvancevichAllergy and Immunology Department, Santa Isabel, Buenos Aires, Argentina.
D Larenas-LinnemannClínica de Alergia, Asma y Pediatría, Hospital Médica Sur, Mexico, Mexico.
J Millot-KeurinckCaisse Assurance Retraite et Santé Au Travail Languedoc-Roussillon (CARSAT-LR), 34000 Montpellier, France.
D RyanAllergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
B SamolinskiDepartment of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
A SheikhAsthma UK Centre for Applied Research, Centre of Medical Informatics, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
A YorganciogluDepartment of Pulmonology, Celal Bayar University, Manisa, Turkey.
I AgacheFaculty of Medicine, Transylvania University, Brasov, Romania.
S ArnavielheKyomed, Montpellier, France.
M BewickiQ4U Consultants Ltd, London, UK.
I Annesi-MaesanoEPAR U707 INSERM, Paris and EPAR UMR-S UPMC, Paris VI, Paris, France.
J M AntoCentre for Research in Environmental Epidemiology (CREAL), ISGLoBAL, Barcelona, Spain.
K C BergmannComprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
C Bindslev-JensenDepartment of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark.
S Bosnic-AnticevichWoolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW Australia.
J BouchardLaval's University, Quebec City, Canada.
D P CaimmiCHRU de Montpellier, Sorbonne Universités, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, 75013 Paris, France.
P CamargosDepartment of Pediatrics, Medical School, Federal University of Minas Gerais, Belo Horizonte, Brazil.
G W CanonicaCHRU de Montpellier, Sorbonne Universités, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, 75013 Paris, France.
V CardonaAllergologia, S Medicina Interna, Hospital Vall d'Hebron, Barcelona, Spain.
A M CarriazoRegional Ministry of Health of Andalusia, Seville, Spain.
C CingiENT Department, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey.
E ColganDepartment of Health, Social Services and Public Safety, Belfast, Northern Ireland, UK.
A CustovicDepartment of Pediatric, Imperial College London, London, UK.
R DahlProAR - Nucleo de Excelencia em Asma, Federal University of Bahia, Salvador, Brazil.
P DemolyDepartment of Respiratory Diseases, Montpellier University Hospital, Montpellier, France.
G De VriesPeercode DV, Gerdermalsen, The Netherlands.
W J FokkensDepartment of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
J F FontaineAllergist, Reims, France.
B GemicioğluDepartment of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.
N GuldemondInstitute of Health Policy and Management iBMG, Erasmus University, Rotterdam, The Netherlands.
Z GutterUniversity Hospital Olomouc - National eHealth Centre, Olomouc, Czech Republic.
T HaahtelaSkin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland.
B Hellqvist-DahlDepartment of Respiratory Diseases, Odense University Hospital, Odense, Denmark.
E JaresLibra Foundation, Buenos Aires, Argentina.
G JoosDepartment of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
J JustAllergology Department, Centre de l'Asthme et des Allergies Hôpital d'Enfants Armand-Trousseau (APHP), Paris, France.
N KhaltaevGARD Chairman, Geneva, Switzerland.
T KeilInstitute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
L KlimekCenter for Rhinology and Allergology, Wiesbaden, Germany.
M L KowalskiDepartment of Immunology, Rheumatology and Allergy, Medical University of Lodz, and HARC, Lodz, Poland.
I KullDepartment of Clinical Science and Education, Södersjukhuset, Karolinska Institutet Stockholm, Stockholm, Sweden.
P KunaDivision of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland.
V KvedarieneClinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University, Vilnius, Lithuania.
D LauneKyomed, Montpellier, France.
R LouisDepartment of Pulmonary Medicine, CHU Sart-Tilman, Liege, Belgium.
A MagnanService de Pneumologie, UMR INSERM, UMR1087 and CNR 6291, l'institut du thorax, University of Nantes, Nantes, France.
J MalvaInstitute of Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
E Mathieu-DupasKyomed, Montpellier, France.
E MelénSachs' Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
E MendittoCIRFF, Federico II University, Naples, Italy.
M Morais-AlmeidaAllergy and Clinical Immunology Department, Hospital CUF-Descobertas, Lisbon, Portugal.
R MösgesInstitute of Medical Statistics, Informatics and Epidemiology, Medical Faculty, University of Cologne, Cologne, Germany.
J MullolClinical and Experimental Respiratory Immunoallergy, ENT Department, Hospital Clínic, IDIBAPS, CIBERES, Universitat de Barcelona, Barcelona, Spain.
R MurrayMedical Communications Consultant, MedScript Ltd, Dundalk, Co Louth Ireland.
H NeffenArgentina Center for Allergy and Immunology, Alassia Children's Hospital, Santa Fe, Santa Fe, Argentina.
R O'HehirDepartment of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC Australia.
S PalkonenEFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
N G PapadopoulosCenter for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, M13 9WL UK.
G PassalacquaAllergy and Respiratory Diseases, IRCCS San Martino Hospital, IST-University of Genoa, Genoa, Italy.
J L PépinCHU Grenoble, La Tronche, France.
F PortejoieContre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France.
D PriceObservational and Pragmatic Research Institute, Singapore, Singapore.
B PuginLaboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Louvain, Belgium.
F RaciborskiDepartment of Prevention of Envinronmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
F E R SimonsDepartment of Pediatrics and Child Health, Department of Immunology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba Canada.
M SovaUniversity Hospital Olomouc, Olomouc, Czech Republic.
O SprangerGlobal Allergy and Asthma Platform GAAPP, Altgasse 8-10, 1130 Vienna, Austria.
C StellatoDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
A Todo BomImunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
P V TomazicDepartment of ENT, Medical University of Graz, Graz, Austria.
M TriggianiDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
A ValeroPneumology and Allergy Department Hospital Clínic, Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
E ValovirtaPneumology and Allergy Department Hospital Clínic, Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain.
O VandenPlasDepartment of Chest Medicine, Centre Hospitalier Universitaire UCL Namur, Université Catholique de Louvain, Yvoir, Belgium.
A ValiulisDepartment of Chest Medicine, Centre Hospitalier Universitaire UCL Namur, Université Catholique de Louvain, Yvoir, Belgium.
M van EerdPeercode DV, Gerdermalsen, The Netherlands.
M T VenturaUnit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy.
M WickmanSachs' Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
I YoungQueen's University Belfast, Belfast, Northern Ireland, UK.
T ZuberbierComprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
A ZurkuhlenGesundheitsregion KölnBonn - HRCB Projekt GmbH, Kohln, Germany.
A SennEC-CNECT-H2, European Commission, Brussels, Belgium.
Funding
Medical Research Council G1000758
Abstract
A Good Practice is a practice that works well, produces good results, and is recommended as a model. MACVIA-ARIA Sentinel Network (MASK), the new Allergic Rhinitis and its Impact on Asthma (ARIA) initiative, is an example of a Good Practice focusing on the implementation of multi-sectoral care pathways using emerging technologies with real life data in rhinitis and asthma multi-morbidity. The European Union Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS) has developed a checklist of 28 items for the evaluation of Good Practices. SUNFRAIL (Reference Sites Network for Prevention and Care of Frailty and Chronic Conditions in community dwelling persons of EU Countries), a European Union project, assessed whether MASK is in line with the 28 items of JA-CHRODIS. A short summary was proposed for each item and 18 experts, all members of ARIA and SUNFRAIL from 12 countries, assessed the 28 items using a Survey Monkey-based questionnaire. A visual analogue scale (VAS) from 0 (strongly disagree) to 100 (strongly agree) was used. Agreement equal or over 75% was observed for 14 items (50%). MASK is following the JA-CHRODIS recommendations for the evaluation of Good Practices.
Indexed as
ARIAAsthmaCHRODISGood PracticesMASKRhinitisSunfrail
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.